Fever in the ICU

Chest

Volumn 117, Issue 3, 2000, Pages 855-869

  Marik, Paul E ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

Cytokines; Fever; ICU; Sinusitis; Tract infection; Urinary; Ventilator associated pneumonia

Indexed keywords

BACTERIAL PNEUMONIA; HOSPITAL INFECTION; HUMAN; INFECTION RISK; INTENSIVE CARE; PRIORITY JOURNAL; REVIEW; SEPSIS; SINUSITIS; URINARY TRACT INFECTION;

EID: 0034102143     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.117.3.855     Document Type: Review

References (219)

1. 1 Meduri GU, Mauldin GL, Wunderink RG, et al. Causes of fever and pulmonary densities in patients with clinical manifestations of ventilator-associated pneumonia. Chest 1994; 106:221-235
2. 2 Mackowiak PA. Concepts of fever. Arch Intern Med 1998; 158:1870-1881
3. 3 Saper CB, Breder CD. The neurologic basis of fever. N Engl J Med 1994; 330:1880-1886
4. 4 Dinarello CA, Cannon JG, Mancilla J. Interleukin-6 as an endogenous pyrogen: induction of prostaglandin E2 in brain but not peripheral blood mononuclear cells. Brain Res 1991; 562:199-206
5. 5 Dinarello CA, Wolff SM. The role of interleukin-1 in disease. N Engl J Med 1993; 328:106-113
6. 6 Dinarello CA, Cannon JG, Mier JW, et al. Multiple biological activities of human recombinant interleukin 1. J Clin Invest 1986; 77:1734-1739
7. 7 Dinarello CA. Interleukin-1 and the pathogenesis of the acute-phase response. N Engl J Med 1984; 311:1413-1418
8. 8 Fontana A, Weber E, Dayer JM. Synthesis of interleukin 1/endogenous pyrogen in the brain of endotoxin-treated mice: a step in fever induction? J Immunol 1984; 133:1696-1698
9. 9 Gourine AV, Rudolph K, Tesfaigzi J, et al. Role of hypothalamic interleukin-1 beta in fever induced by cecal ligation and puncture in rats. Am J Physiol 1998; 275(3 Pt 2):R754-R761
10. 10 Leon LR, White AA, Kluger MJ. Role of IL-6 and TNF in thermoregulation and survival during sepsis in mice. Am J Physiol 1998; 275(1 Pt 2):R269-R277
11. 11 Kluger MJ, Kozak W, Leon LR, et al. The use of knockout mice to understand the role of cytokines in fever. Clin Exp Pharmacol Physiol 1998; 25:141-144
12. 12 Klir JJ, McClellan JL, Kluger MJ. Interleukin-1 beta causes the increase in anterior hypothalamic interleukin-6 during LPS-induced fever in rats. Am J Physiol 1994; 266(6 Pt 2):R1845-R1848
13. 13 Klir JJ, Roth J, Szelenyi Z, et al. Role of hypothalamic interleukin-6 and tumor necrosis factor-alpha in LPS fever in rat. Am J Physiol 1993; 265(3 Pt 2):R512-R517
14. 14 Mackowiak PA, Bartiett JG, Borden EC, et al. Concepts of fever: recent advances and lingering dogma. Clin Infect Dis 1997; 25:119-138
15. 15 Kluger MJ, Kozak W, Conn CA, et al. The adaptive value of fever. Infect Dis Clin N Am 1996; 10:1-20
16. 16 Kluger MJ, Vaughn LK. Fever and survival in rabbits infected with Pasteurella multocida. J Physiol 1978; 282: 243-251
17. 17 Bernheim HA, Kluger MJ. Fever and antipyresis in the lizard Dipsosaurus dorsalis. Am J Physiol 1976; 231:198-203
18. 18 D'Alecy LG, Kluger MJ. Avian febrile response. J Physiol 1975; 253:223-232
19. 19 Vaughn LK, Bernheim HA, Kluger MJ. Fever in the lizard Dipsosaurus dorsalis. Nature 1974; 252:473-474
20. 20 Covert JB, Reynolds WW. Survival value of fever in fish. Nature 1977; 267:43-45
21. 21 Bernheim HA, Kluger MJ. Fever: effect of drug-induced antipyresis on survival. Science 1976; 193:237-239
22. 22 Kluger MJ, Ringler DH, Anver MR. Fever and survival. Science 1975; 188:166-168
23. 23 Jampel HD, Duff GW, Gershon RK, et al. Fever and immunoregulation: III. Hyperthermia augments the primary in vitro humoral immune response. J Exp Med 1983; 157:1229-1238
24. 24 van Oss CJ, Absolom DR, Moore LL, et al. Effect of temperature on the chemotaxis, phagocytic engulfment, digestion and O2 consumption of human polymorphonuclear leukocytes. J Reticuloendothel Soc 1980; 27:561-565
25. 25 Biggar WD, Bohn DJ, Kent G, et al. Neutrophil migration in vitro and in vivo during hypothermia. Infect Immunol 1984; 46:857-859
26. 26 Azocar J, Yunis EJ, Essex M. Sensitivity of human natural killer cells to hyperthermia. Lancet 1982; 1:16-17
27. 27 Styrt B, Sugarman B. Antipyresis and fever. Arch Intern Med 1990; 150:1589-1597
28. 28 Dennie CC. A history of syphilis. Springfield, IL: Charles C. Thomas, 1962
29. 29 Small PM, Tauber MG, Hackbarth CJ, et al. Influence of body temperature on bacterial growth rates in experimental pneumococcal meningitis in rabbits. Infect Immunol 1986; 52:484-487
30. 30 Sande MA, Sande ER, Woolwine JD, et al. The influence of fever on the development of experimental Streptococcus pneumoniae meningitis. J Infect Dis 1987; 156:849-850
31. 31 Anderson KJ, Kuhn RE. Elevated environmental temperature enhances immunity in experimental Chagas' disease. Infect Immunol 1989; 57:13-17
32. 32 Carmichael LE, Barnes FD, Percy DH. Temperature as a factor in resistance of young puppies to canine herpesvirus. J Infect Dis 1969; 120:669-678
33. 33 Bryant RE, Hood AF, Hood CE, et al. Factors affecting mortality of gram-negative rod bacteremia. Arch Intern Med 1971; 127:120-128
34. 34 Weinstein MR, Iannini PB, Stratton CW, et al. Spontaneous bacterial peritonitis: a review of 28 cases with emphasis on improved survival and factors influencing prognosis. Am J Med 1978; 64:592-598
35. 35 Dorn TF, DeAngelis C, Baumgardner RA, et al. Acetaminophen: more harm than good for chickenpox? J Pediatr 1989; 114:1045-1048
36. 36 Manthous CA, Hall JB, Olson D, et al. Effect of cooling on oxygen consumption in febrile critically ill patients. Am J Respir Crit Care Med 1995; 151:10-14
37. 37 Ginsberg MD, Busto R. Combating hyperthermia in acute stroke: a significant clinical concern. Stroke 1998; 29:529-534
38. 38 Badawi N, Kurinczuk JJ, Keogh JM, et al. Intrapartum risk factors for newborn encephalopathy: the Western Australian case-control study. BMJ 1998; 317:1554-1558
39. 39 Quinn M, Matthews TG. Does maternal pyrexia embarrass the fetus? Irish Med J 1984; 77:218-219
40. 40 Schmitz T, Bair N, Falk M, et al. A comparison of five methods of temperature measurement in febrile intensive care patients. Am J Crit Care 1995; 4:286-292
41. 41 Milewski A, Ferguson KL, Terndrup TE. Comparison of pulmonary artery, rectal, and tympanic membrane temperatures in adult intensive care unit patients. Clin Pediatr 1991; 30(4 Suppl):13-16
42. 42 Nierman DM. Core temperature measurement in the intensive care unit. Crit Care Med 1991; 19:818-823
43. 43 Erickson RS, Kirklin SK. Comparison of ear-based, bladder, oral, and axillary methods for core temperature measurement. Crit Care Med 1993; 21:1528-1534
44. 44 Hayward JS, Eckerson JD, Kemna D. Thermal and cardiovascular changes during three methods of resuscitation from mild hypothermia. Resuscitation 1984; 11:21-33
45. 45 Shiraki K, Konda N, Sagawa S. Esophageal and tympanic temperature responses to core blood temperature changes during hyperthermia. J Appl Physiol 1986; 61:98-102
46. 46 Shiraki K, Sagawa S, Tajima F, et al. Independence of brain and tympanic temperatures in an unanesthetized human. J Appl Physiol 1988; 65:482-486
47. 47 O'Grady NP, Barie PS, Bartlett J, et al. Practice parameters for evaluating new fever in critically ill adult patients. Crit Care Med 1998; 26:392-408
48. 48 Musher DM, Fainstein V, Young EJ, et al. Fever patterns: their lack of clinical significance. Arch Intern Med 1979; 139:1225-1228
49. 49 Chastre J, Fagon JY, Trouillet JL. Diagnosis and treatment of nosocomial pneumonia in patients in intensive care units. Clin Infect Dis 1995; 21(Suppl 3):S226-S237
50. 50 Kollef MH. Ventilator-associated pneumonia: a multivariate analysis. JAMA 1993; 270:1965-1970
51. 51 Hiyama DT, Zinner MJ. Surgical complications. In: Schwartz SI, Shires GT, Spencer FC et al, eds. Principles of surgery. New York, NY: McGraw-Hill, 1994; 455-487
52. 52 Calandra T, Bille J, Schneider R, et al. Clinical significance of Candida isolated from peritoneum in surgical patients. Lancet 1989; 2:1437-1440
53. 53 Petri MG, Konig J, Moecke HP, et al. Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Paul-Ehrlich Society for Chemotherapy, Divisions of Mycology and Pneumonia Research. Intensive Care Med 1997; 23:317-325
54. 54 Nolla-Salas J, Sitges-Serra A, Leon-Gil G, et al. Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU. Intensive Care Med 1997; 23:23-30
55. 55 Ferrara JL. The febrile platelet transfusion reaction: a cytokine shower. Transfusion 1995; 35:89-90
56. 56 Chen CC, Wang SS, Lee FY, et al. Proinflammatory cytokines in early assessment of the prognosis of acute pancreatitis. Am J Gastroenterol 1999; 94:213-218
57. 57 Osman MO, El-Sefi T, Lausten SB, et al. Sodium fusidate and the cytokine response in an experimental model of acute pancreatitis. Br J Surg 1998; 85:1487-1492
58. 58 Feuerstein GZ, Wang X, Barone FC. The role of cytokines in the neuropathology of stroke and neurotrauma. Neuroimmunomodulation 1998; 5:143-159
59. 59 DeGraba TJ. The role of inflammation after acute stroke: utility of pursuing anti-adhesion molecule therapy. Neurology 1998; 51(3 Suppl 3):S62-S68
60. 60 Carlstedt F, Lind L, Lindahl B. Proinflammatory cytokines, measured in a mixed population on arrival in the emergency department, are related to mortality and severity of disease. J Intern Med 1997; 242:361-365
61. 61 Marx N, Neumann FJ, Ott I, et al. Induction of cytokine expression in leukocytes in acute myocardial infarction. J Am Coll Cardiol 1997; 30:165-170
62. 62 Clemmer TP, Fisher CJ, Jr, Bone RC, et al. Hypothermia in the sepsis syndrome and clinical outcome. The Methylprednisolone Severe Sepsis Study Group. Crit Care Med 1992; 20:1395-1401
63. 63 Sprung CL, Peduzzi PN, Shatney CH, et al. Impact of encephalopathy on mortality in the sepsis syndrome. The Veterans Administration Systemic Sepsis Cooperative Study Group. Crit Care Med 1990; 18:801-806
64. 64 Arons MM, Wheeler AP, Bernard GR, et al. Effects of ibuprofen on the physiology and survival of hypothermie sepsis. Crit Care Med 1999; 27:699-707
65. 65 Marik PE, Zaloga GP. Hypothermia and cytokines in septic shock [abstract]. Crit Care Med 1999; 27(Suppl):A136
66. 66 Clarke DE, Kimelman J, Raffin TA. The evaluation of fever in the intensive care unit. Chest 1991; 100:213-220
67. 67 Cunha BA. Fever in the critical care unit. Crit Care Clin 1998; 14:1-14
68. 68 Chambers LA, Kruskall MS, Pacini DG, et al. Febrile reactions after platelet transfusion: the effect of single versus multiple donors. Transfusion 1990; 30:219-221
69. 69 Hanson MA. Drug fever: remember to consider it in diagnosis. Postgrad Med 1991; 89:167-170
70. 70 Mackowiak PA, LeMaistre CF. Drug fever: a critical appraisal of conventional concepts; an analysis of 51 episodes in two Dallas hospitals and 97 episodes reported in the English literature. Ann Intern Med 1987; 106:728-733
71. 71 Mackowiak PA. Drug fever: mechanisms, maxims and misconceptions. Am J Med Sci 1987; 294:275-286
72. 72 Barton JC. Nonhemolytic, noninfectious transfusion reactions. Semin Hematol 1981; 18:95-121
73. 73 Rutledge R, Sheldon GF, Collins ML. Massive transfusion. Crit Care Clin 1986; 2:791-805
74. 74 Wood AJJ. Adverse drug reactions. In: Fauci AS, Braunwald E, Isselbacher KJ et al, eds. Harrison's principles of internal medicine. New York, NY: McGraw-Hill, 1998; 422-430
75. 75 Fry DE. Postoperative fever. In: Mackowiak PA, ed. Fever: basic mechanisms and management. New York, NY: Raven Press, 1991; 243-254
76. 76 Engoren M. Lack of association between atelectasis and fever. Chest 1995; 107:81-84
77. 77 Shields RT. Pathogenesis of postoperative pulmonary atelectasis an experimental study. Arch Surg 1949; 48:489-503
78. 78 Lansing AM. Mechanism of fever in pulmonary atelectasis. Arch Surg 1963; 87:168-174
79. 79 Kisala JM, Ayala A, Stephan RN, et al. A model of pulmonary atelectasis in rats: activation of alveolar macrophage and cytokine release. Am J Physiol 1993; 264(3 Pt 2):R610-R614
80. 80 Menitove JE, Mc Elligott MC, Aster RH. Febrile transfusion reaction: what blood component should be given next? Vox Sanguinis 1982; 42:318-321
81. 81 Snyder EL, Stack G. Febrile and nonimmune transfusions reactions. In: Rossi EC, Simon TL, Moss GS, eds. Principles of transfusion medicine. Baltimore, MD: Williams and Wilkins, 1991
82. 82 Fenwick JC, Cameron M, Naiman SC, et al. Blood transfusion as a cause of leucocytosis in critically ill patients. Lancet 1994; 344:855-856
83. 83 Meduri GU, Belenchia JM, Estes RJ, et al. Fibroproliferative phase of ARDS: clinical findings and effects of corticosteroids. Chest 1991; 100:943-952
84. 84 Meduri GU, Headley S, Golden E, et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 1999; 280:159-165
85. 85 Orlando R, Gleason E, Drezner AD. Acute acalculous cholecystitis in the critically ill patient. Am J Surg 1983; 145:472-476
86. 86 Long TN, Heimbach DM, Carrico CJ. Acalculous cholecystitis in critically ill patients. Am J Surg 1978; 136:31-36
87. 87 Johnson EE, Hedley-White J. Continuous positive-pressure ventilation and portal flow in dogs with pulmonary edema. J Appl Physiol 1972; 33:385-389
88. 88 Johnson EE, Hedley-White J. Continuous positive pressure ventilation and choledochoduodenal flow resistance. J Appl Physiol 1975; 39:937-942
89. 89 Barie PS, Fischer E. Acute acalculous cholecystitis. J Am Coll Surg 1995; 180:232-244
90. 90 Malet PF. Acalculous cholecystitis: a new perspective. Gastroenterology 1990; 99:1529-1530
91. 91 Roslyn JJ, Pitt HA, Mann L, et al. Parenteral nutrition-induced gallbladder disease: a reason for early cholecystectomy. Am J Surg 1984; 148:58-63
92. 92 Petersen SR, Sheldon GF. Acute acalculous cholecystitis: a complication of hyperalimentation. Am J Surg 1979; 138: 814-817
93. 93 Deitch EA, Engel JM. Acute acalculous cholecystitis: ultrasonic diagnosis. Am J Surg 1981; 142:290-292
94. 94 Deitch EA. Utility and accuracy of ultrasonically measured gallbladder wall as a diagnostic criteria in biliary tract disease. Dig Dis Sci 1981; 26:686-693
95. 95 Kalff V, Froelich JW, Lloyd R, et al. Predictive value of an abnormal hepatobiliary scan in patients with severe inter-current illness. Radiology 1983; 146:191-194
96. 96 Blankenberg F, Wirth R, Jeffrey RBJ, et al. Computed tomography as an adjunct to ultrasound in the diagnosis of acute acalculous cholecystitis. Gastrointest Radiol 1991; 16:149-153
97. 97 Roslyn JJ, Zinner MJ. Gallbladder and extrahepatic biliary system. In: Schwartz SI, Shires GT, Spencer FC et al, ed. Principles of surgery. New York, NY: McGraw-Hill, 1994; 1367-1399
98. 98 Kiviniemi H, Makela JT, Autio R, et al. Percutaneous cholecystostomy in acute cholecystitis in high-risk patients: an analysis of 69 patients. Int Surg 1998; 83:299-302
99. 99 van Overhagen H, Meyers H, Tilanus HW, et al. Percutaneous cholecystectomy for patients with acute cholecystitis and an increased surgical risk. Cardiovasc Intervent Radiol 1996; 19:72-76
100. 100 Diamond PT, Macciocchi SN. Predictive power of clinical symptoms in patients with presumptive deep venous thrombosis. Am J Phys Med Rehabil 1997; 76:49-51
101. 101 Marik PE, Andrews L, Maini B. The incidence of deep venous thrombosis in ICU patients. Chest 1997; 111:661-664
102. 102 Brown RB, Hosmer D, Chen HC, et al. A comparison of infections in different ICU's within the same hospital. Crit Care Med 1985; 13:472-476
103. 103 Jarvis WR, Edwards JR, Culver DH, et al. Nosocomial infection rates in adult and pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System. Am J Med 1991; 91(3B):185S-191S
104. 104 Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe: results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995; 274:639-644
105. 105 Daschner FD, Frey P, Wolff G, et al. Nosocomial infections in intensive care wards: a multicenter prospective study. Intensive Care Med 1982; 8:5-9
106. 106 Bueno-Cavanillas A, Delgado-Rodriguez M, Lopez-Luque A, et al. Influence of nosocomial infection on mortality rate in an intensive care unit. Crit Care Med 1994; 22:55-60
107. 107 Bjerke HS, Leyerle B, Shabot MM. Impact of ICU nosocomial infections on outcome from surgical care. Am Surg 1991; 57:798-802
108. 108 Potgieter PD, Linton DM, Oliver S, et al. Nosocomial infections in a respiratory intensive care unit. Crit Care Med 1987; 15:495-498
109. 109 Haley RW, Quade D, Freeman HE, et al. Study on the efficacy of nosocomial infection control (SENIC Project): summary of study design. Am J Epidemiol 1980; 111:472-485
110. 110 Garner JS, Jarvis WR, Emorl TG, et al. CDC definitions for nosocomial infections. Am J Infect Control 1988; 16:128-140
111. 111 Baker AM, Bowton DL, Haponik EF. Decision making in nosocomial pneumonia: an analytic approach to the interpretation of quantitative bronchoscopic cultures. Chest 1995; 107:85-95
112. 112 Chastre J, Trouillet JL, Fagon JY. Diagnosis of pulmonary infections in mechanically ventilated patients. Semin Respir Infect 1996; 11:65-76
113. 113 Fagon JY, Chastre J, Domart Y, et al. Nosocomial pneumonia in patients receiving continuous mechanical ventilation: prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques. Am Rev Respir Dis 1989; 139:877-884
114. 114 Meduri GU. Diagnosis and differential diagnosis of ventilator-associated pneumonia. Clin Chest Med 1995; 16:61-93
115. 115 Fagon JY, Chastre J, Hance AJ, et al. Detection of nosocomial lung infection in ventilated patients: use of a protected specimen brush and quantitative culture in 147 patients. Am Rev Respir Dis 1988; 138:110-116
116. 116 Torres A, Aznar R, Gatell JM, et al. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis 1990; 142:523-528
117. 117 Timsit JF, Chevret S, Valcke J, et al. Mortality of nosocomial pneumonia in ventilated patients: influence of diagnostic tools. Am J Respir Crit Care Med 1996; 154:116-123
118. 118 Timsit JF, Misset B, Goldstein FW, et al. Reappraisal of distal diagnostic testing in the diagnosis of ICU-acquired pneumonia. Chest 1995; 108:1632-1639
119. 119 Craig CP, Connelley S. Effect of intensive care unit nosocomial pneumonia on duration and mortality. Am J Infect Control 1984; 12:233-238
120. 120 Bregeon F, Papazian L, Visconti A, et al. Relationship of microbiologic diagnostic criteria to morbidity and mortality in patients with ventilator-associated pneumonia. JAMA 1997; 277:655-662
121. 121 Fagon JY, Chastre J, Hance AJ, et al. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 1993; 94:281-288
122. 122 Fagon JY, Chastre J, Hance AJ, et al. Evaluation of clinical judgment in the identification and treatment of nosocomial pneumonia in ventilated patients. Chest 1993; 103:547-553
123. 123 Marik PE, Brown WJ. A comparison of bronchoscopic vs blind protected specimen brush sampling in patients with suspected ventilator-associated pneumonia. Chest 1995; 108:203-207
124. 124 Chastre J, Fagon JY, Bornet-Lecso M, et al. Evaluation of bronchoscopic techniques for the diagnosis of nosocomial pneumonia. Am J Respir Crit Care Med 1995; 152:231-240
125. 125 Kollef MH, Bock KR, Richards RD, et al. The safety and diagnostic accuracy of minibronchoalveolar lavage in patients with suspected ventilator-associated pneumonia. Ann Intern Med 1995; 122:743-748
126. 126 Allaouchiche B, Jaumain H, Dumontet C, et al. Early diagnosis of ventilator-associated pneumonia: is it possible to define a cutoff value of infected cells in BAL fluid? Chest 1996; 110:1558-1565
127. 127 Speich R, Wust J, Hess T, et al. Prospective evaluation of a semiquantitative dip slide method compared with quantitative bacterial cultures of BAL fluid. Chest 1996; 109:1423-1429
128. 128 Kollef MH, Eisenberg PR, Ohlendorf MF, et al. The accuracy of elevated concentrations of endotoxin in bronchoalveolar lavage fluid for the rapid diagnosis of gram-negative pneumonia. Am J Respir Crit Care Med 1996; 154:1020-1028
129. 129 Timset JF, Misset B, Azoulay E, et al. Usefulness of airway visualization in the diagnosis of nosocomial pneumonia in ventilated patients. Chest 1996; 110:172-179
130. 130 Jourdain B, Joly-Guillou ML, Dombret MC, et al. Usefulness of quantitative cultures of BAL fluid for diagnosing nosocomial pneumonia in ventilated patients. Chest 1997; 111:411-418
131. 131 Torres A, el-Ebiary M, Fabregas N, et al. Value of intracellular bacteria detection in the diagnosis of ventilator associated pneumonia. Thorax 1996; 51:378-384
132. 132 el-Ebiary M, Torres A, Gonzalez J, et al. Quantitative cultures of endotracheal aspirates for the diagnosis of ventilator-associated pneumonia. Am Rev Respir Dis 1993; 148:1552-1557
133. 133 Marquette GH, Copin MC, Wallet F, et al. Diagnostic tests for pneumonia in ventilated patients: prospective evaluation of diagnostic accuracy using histology as a diagnostic gold standard. Am J Respir Crit Care Med 1995; 151:1878-1888
134. 134 Kirdand SH, Corely DE, Winterbauer RH, et al. The diagnosis of ventilator-associated pneumonia: a comparison of histologic, microbiologic, and clinical criteria. Chest 1997; 112:445-457
135. 135 Corely DE, Kirdand SH, Winterbauer RH, et al. Reproducibility of the histologic diagnosis of pneumonia among a panel of four pathologists: analysis of a gold standard. Chest 1997; 112:458-465
136. 136 Sterling TR, Ho EJ, Brehm WT, et al. Diagnosis and treatment of ventilator-associated pneumonia: impact on survival; a decision analysis. Chest 1996; 110:1025-1034
137. 137 Luna CM, Vujacich P, Niederman MS, et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 1997; 111:676-685
138. 138 Rello J, Gallego M, Mariscal D, et al. The value of routine microbial investigation in ventilator-associated pneumonia. Am J Respir Crit Care Med 1997; 156:196-200
139. 139 Kollef MH, Ward S. The influence of mini-BAL cultures on patients outcomes: implications for the antibiotic management of ventilator-associated pneumonia. Chest 1998; 113: 412-420
140. 140 Wearden PD, Chendrasekhar A, Timberlake GA. Comparison of nonbronchoscopic techniques with bronchoscopic brushing in the diagnosis of ventilator-associated pneumonia. J Trauma 1996; 41:703-707
141. 141 Bello S, Tajada A, Chacon E, et al. "Blind" protected specimen brushing versus bronchoscopic techniques in the aetiolological diagnosis of ventilator-associated pneumonia. Eur Respir J 1996; 9:1494-1499
142. 142 Papazian L, Thomas P, Garbe L, et al. Bronchoscopic or blind sampling techniques for the diagnosis of ventilator-associated pneumonia. Am J Respir Crit Care Med 1995; 152:1982-1991
143. 143 Leal-Noval SR, Alfaro-Rodriguez E, Murillo-Cabeza F, et al. Diagnostic value of the blind brush in mechanically-ventilated patients with nosocomial pneumonia. Intensive Care Med 1992; 18:410-414
144. 144 Rouby JJ, De Lassale EM, Poete P, et al. Nosocomial bronchopneumonia in the critically ill: histologic and bacteriologic aspects. Am Rev Respir Dis 1992; 146:1059-1066
145. 145 Marik PE, Careau P. A comparison of mini-bronchoalveolar lavage and blind-protected specimen brush sampling in ventilated patients with suspected pneumonia. J Crit Care 1998; 13:67-72
146. 146 Grindlinger GA, Niehoff J, Hughes L, et al. Acute paranasal sinusitis related to nasotracheal intubation of head-injured patients. Crit Care Med 1987; 15:214-217
147. 147 Deutschman CS, Wilton P, Sinow J, et al. Paranasal sinusitis associated with nasotracheal intubation: a frequently unrecognized and treatable source of sepsis. Crit Care Med 1986; 14:111-114
148. 148 Rouby JJ, Laurent P, Gosnach M, et al. Risk factors and clinical relevance of nosocomial maxillary sinusitis in the critically ill. Am J Respir Crit Care Med 1994; 150:776-783
149. 149 Fassoulaki A, Pamouktsoglou P. Prolonged nasotracheal intubation and its association with inflammation of paranasal sinuses. Anesth Analg 1989; 69:50-52
150. 150 Holzapfel L, Chastang C, Demingeon G, et al. Randomized study assessing the systematic search for maxillary sinusitis in nasotracheally mechanically ventilated patients. Am J Respir Crit Care Med 1999; 159:695-701
151. 151 Hansen M, Poulsen MR, Bendixen DK, et al. Incidence of sinusitis in patients with nasotracheal intubation. Br J Anaesth 1988; 61:231-232
152. 152 Zinreich SJ. Paranasal sinus imaging. Otolaryngol Head Neck Surg 1990; 103:863-869
153. 153 Holzapfel L, Chevret S, Madinier G, et al. Influence of long-term oro-or nasotracheal intubation on nosocomial maxillary sinusitis and pneumonia: results of a prospective, randomized, clinical trial. Crit Care Med 1993; 21:1132-1138
154. 154 Darouiche R, Raad I, Heard SO, et al. A comparison of two antimicrobial-impregnated central venous catheters. N Engl J Med 1999; 340:1-8
155. 155 Maid DG. Pathogenesis, prevention, and management of infections due to intravascular devices used for infusion therapy. In: Bisno A, Waldvogel F, eds. Infections associated with indwelling medical devices. Washington, DC: American Society for Microbiology, 1989; 161-177
156. 156 Mimoz O, Pieroni L, Lawrence C, et al. Prospective, randomized trial of two antiseptic solutions for prevention of central venous or arterial catheter colonization and infection in intensive care unit patients. Crit Care Med 1996; 24: 1818-1823
157. 157 Tacconelli E, Tumbarello M, Pittiruti M, et al. Central venous catheter-related sepsis in a cohort of 366 hospitalized patients. Eur J Clin Microbiol Infect Dis 1997; 16:203-209
158. 158 Wenzel RP, Edmond MB. The evolving technology of venous access. N Engl J Med 1991; 340:48-49
159. 159 Maid DG, Brand JD. A comparative study of polyantibiotic and iodophor ointments in prevention of vascular catheter-related infection. Am J Med 1981; 70:739-744
160. 160 Timsit JF, Sebille V, Farkas JC, et al. Effect of subcutaneous tunneling on internal jugular catheter-related sepsis in critically ill patients: a prospective randomized multicenter study. JAMA 1996; 276:1416-1420
161. 161 Flowers RI, Schwenzer J, Kopel RF. Efficacy of an attachable subcutaneous cuff for the prevention of intravascular catheter-related infection: a randomized controlled trial. JAMA 1989; 261:878-883
162. 162 Hasaniya NWMA, Angelis M, Brown MR, et al. Efficacy of subcutaneous silver-impregnated cuffs in preventing central venous catheter infections. Chest 1996; 109:1030-1032
163. 163 Raad I, Darouiche R. Prevention of infections associated with intravascular devices. Curr Opin Crit Care 1996; 2:361-365
164. 164 Raad I, Darouiche RO, Hachem R, et al. Antimicrobial durability and rare ultrastructural colonization of indwelling central catheters coated with minocycline and rifampin. Crit Care Med 1998; 26:219-224
165. 165 Raad I, Darouiche R, Dupuis J, et al. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and blood stream infections: a randomized, double-blind trial. Ann Intern Med 1997; 127:267-274
166. 166 Maki DG, Stolz SM, Wheeler S, et al. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter: a randomized, controlled trial. Ann Intern Med 1997; 127:257-266
167. 167 Civatta JM, Hudson-Civatta J, Ball S. Decreasing catheter-related infection and hospital costs by continuous quality improvement. Crit Care Med 1996; 24:1660-1665
168. 168 Sherertz RJ, Hard SO, Raad II, et al. Gamma radiation-sterilized, triple-lumen catheters coated with a low concentration of chlorhexidine were not efficacious at preventing catheter infections in intensive care unit patients. Antimicrob Agents Chemother 1996; 40:1995-1997
169. 169 Pemberton LB, Ross V, Cuddy P, et al. No difference in catheter sepsis between standard and antiseptic central venous catheters: a prospective randomized trial. Arch Surg 1996; 131:986-989
170. 170 Ciresi DL, Albrecht RM, Volkers PA, et al. Failure of antiseptic bonding to prevent central venous catheter-related infection and sepsis. Am Surg 1996; 62:641-646
171. 171 Williams JF, Seneff MG, Friedman BC, et al. Use of femoral venous catheters in critically ill adults: prospective study. Crit Care Med 1991; 19:550-553
172. 172 Cook D, Randolph A, Kernerman P, et al. Central venous catheter replacement strategies: a systemic review of the literature. Crit Care Med 1997; 25:1417-1424
173. 173 Cobb DK, High KP, Sawyer WT, et al. A controlled trial of scheduled replacement of central venous and pulmonary artery catheters. N Engl J Med 1992; 327:1062-1068
174. 174 Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous-catheter related infection. N Engl J Med 1977; 296:1305-1309
175. 175 Raad I, Sabbagh MF, Rand KH, et al. Quantitative tip culture methods and the diagnosis of central venous catheter-related infections. Diagn Microbiol Infect Dis 1991; 15:13-20
176. 176 Sherertz RJ, Raad I, Belani A, et al. Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratory. J Clin Microbiol 1990; 28:76-82
177. 177 Platt R, Polk BF, Murdock B, et al. Mortality associated with nosocomial urinary tract infection. N Engl J Med 1982; 307:637-642
178. 178 Daifuku R, Stamm W. Association of rectal and urethral colonization with urinary tract infection in patients with indwelling catheters. JAMA 1984; 252:2028-2030
179. 179 Stark RP, Maki DG. Bacteriuria in the catheterized patient: what quantitative level of bacteriuria is relevant? N Engl J Med 1984; 311:560-564
180. 180 Brown DF, Warren RE. effect of sample volume on yield of positive blood cultures from adult patients with hematological malignancy. J Clin Pathol 1990; 43:777-779
181. 181 Paradisi F, Corti G, Mangani V. Urosepsis in the critical care unit. Crit Care Clin 1998; 114:165-180
182. 182 Warren JW. Catheter-associated urinary tract infections. Infect Dis Clin North Am 1997; 11:609-619
183. 183 Krieger JN, Kaiser DL, Wenzel RP. Urinary tract etiology of bloodstream infections in hospitalized patients. J Infect Dis 1983; 148:57-62
184. 184 Garibaldi RA, Mooney BR, Epstein BJ, et al. An evaluation of daily bacteriologic monitoring to identify preventable episodes of catheter-associated urinary tract infection. Infect Control 1982; 3:466-470
185. 185 Wilcox MH, Smyth ET. Incidence and impact of Clostridium difficile infection in the UK, 1993-1996. J Hosp Infect 1998; 39:181-187
186. 186 Brazier JS. The epidemiology and typing of Clostridium difficile. J Antimicrob Chemother 1998; 41(Suppl C):47-57
187. 187 Lai KK, Melvin ZS, Menard MJ, et al. Clostridium difficile-associated diarrhea: epidemiology, risk factors, and infection control. Infect Control Hosp Epidemiol 1997; 18:628-632
188. 188 Adams HP, Brott TG, Crowell RM, et al. Guidelines for the management of patients with acute ischemic stroke: a statement for the healthcare professionals from a special writing group of the stroke council, American Heart Association. Circulation 1994; 90:1588-1601
189. 189 Borriello SP. Pathogenesis of Clostridium difficile infection. J Antimicrob Chemother 1998; 41(Suppl C):13-19
190. 190 Manabe YC, Vinetz JM, Moore RD, et al. Clostridium difficile colitis: an efficient clinical approach to diagnosis. Ann Intern Med 1995; 123:835-840
191. 191 Brazier JS. The diagnosis of Clostridium difficile-associated disease. J Antimicrob Chemother 1998; 41(Suppl C):29-40
192. 192 Kelly CP, Pouthoulakis C, LaMont JT Clostridia Difficile Colitis. N Engl J Med 1994; 330:257-262
193. 193 Beck-Sague C, Jarvis WR. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. J Infect Dis 1993; 167:1247-1251
194. 194 Rello J, Esandi ME, Diaz E, et al. The role of Candida sp isolated from bronchoscopic samples in nonneutropenic patients. Chest 1998; 114:146-149
195. 195 el Ebiary M, Torres A, Fabregas N, et al. Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients: an immediate postmortem histologic study. Am J Respir Crit Care Med 1997; 156(2 Pt 1):583-590
196. 196 Adelson-Mitty J, Fink MP, Lisbon A. The value of lumbar puncture in the evaluation of critically ill, non-immunosuppressed, surgical patients: a retrospective analysis of 70 cases. Intensive Care Med 1997; 23:749-752
197. 197 Metersky ML, Williams A, Rafanan AL. Retrospective analysis: are fever and mental status indications for lumbar puncture in a hospitalized patient who has not undergone neurosurgery. Clin Infect Dis 1997; 25:285-288
198. 198 Dotson RG, Pingleton SK. The effect of antibiotic therapy on recovery of intracellular bacteria from bronchoalveolar lavage in suspected ventilator-associated nosocomial pneumonia. Chest 1993; 103:541-546
199. 199 Souweine B, Veber B, Bedos JP, et al. Diagnostic accuracy of protected specimen brush and bronchoalveolar lavage in nosocomial pneumonia: impact of previous antimicrobial treatments. Crit Care Med 1998; 26:236-244
200. 200 Crowe M, Ispahani P, Humphreys H, et al. Bacteraemia in the adult intensive care unit of a teaching hospital in Nottingham, UK, 1985-1996. Eur J Clin Microbiol Infect Dis 1998; 17:377-384
201. 201 Valles J, Leon C, Alvarez-Lerma F. Nosocomial bacteremia in critically ill patients: a multicenter study evaluating epidemiology and prognosis. Spanish Collaborative Group for Infections in Intensive Care Units of Sociedad Espanola de Medicina Intensiva y Unidades Coronarias (SEMIUC). Clin Infect Dis 1997; 24:387-395
202. 202 Brun-Buisson C, Doyon F, Carlet J. Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. French Bacteremia-Sepsis Study Group. Am J Respir Crit Care Med 1996; 154(3 Pt 1):617-624
203. 203 Brun-Buisson C, Doyon F, Carlet J, et al. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults: a multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. JAMA 1995; 274:968-974
204. 204 Levin PD, Hersch M, Rudensky B, et al. Routine surveillance blood cultures: their place in the management of critically ill patients. J Infect 1997; 35:125-128
205. 205 Bennett IL, Beeson RB. Bacteremia: a consideration of some experimental and clinical aspects. Yale J Biol Med 1954; 262:241-262
206. 206 Chandrasekar PH, Brown WJ. Clinical issues of blood cultures. Arch Intern Med 1994; 154:841-849
207. 207 Wormser GP, Onorato IM, Preminger TJ, et al. Sensitivity and specificity of blood cultures obtained through intravascular catheters. Crit Care Med 1990; 18:152-156
208. 208 Ilstrup DM, Washington JA. The importance of volume of blood culture in the detection of bacteremia and fungemia. Diagn Microbiol Infect Dis 1983; 1:107-110
209. 209 Mermel LA, Maki DG. Detection of bacteremia in adults: consequences of culturing an inadequate volume of blood. Ann Intern Med 1993; 119:270-272
210. 210 Levin PD, Yinnon AM, Hersch M, et al. Impact of the resin blood culture medium on the treatment of critically ill patients. Crit Care Med 1996; 24:797-801
211. 211 Davis LP, Fink-Bennett D. Nuclear medicine in the acutely ill patient: II. Crit Care Clin 1994; 10:383-400
212. 212 Meduri GU, Belenchia JM, Massie JD, et al. The role of gallium-67 scintigraphy in diagnosing sources of fever in ventilated patients. Intensive Care Med 1996; 22:395-403
213. 213 Berrouschot J, Sterker M, Bettin S, et al. Mortality of space-occupying ('malignant') middle cerebral artery infarction under conservative intensive care. Intensive Care Med 1998; 24:620-623
214. 214 Clifton GL, Allen S, Barrodale P, et al. A phase II study of moderate hypothermia in severe brain injury. J Neurotrauma 1993; 10:263-271
215. 215 Marion DW, Obrist WD, Carlier PM, et al. The use of moderate therapeutic hypothermia for patients with severe head injuries: a preliminary report. J Neurosurg 1993; 79:354-362
216. 216 Marion DW, Penrod LE, Kelsey SF, et al. Treatment of traumatic brain injury with moderate hypothermia. N Engl J Med 1997; 336:540-546
217. 217 Mackowiak PA. Fever: blessing or curse? A unifying hypothesis. Ann Intern Med 1994; 120:1037-1040
218. 218 O'Donnel J, Axelrod P, Fisher C, et al. Use of and effectiveness of hypothermia blankets for febrile patients in the intensive care unit. Clin Infect Dis 1997; 24:1208-1213
219. 219 Lenhardt R, Negishi C, Sessler DI, et al. The effects of physical treatment on induced fever in humans. Am J Med 1999; 106:550-555